Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction

Overview of attention for article published in ESC Heart Failure, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets

twitter: 9 X users

Readers on

mendeley: 2 Mendeley

Summary News X

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 25,782 followers.

RT @JanBiegus: "Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction" Take a l…

03 Apr 2024

Reply Repost Favourite

RT @JanBiegus: "Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction" Take a l…

02 Apr 2024

Reply Repost Favourite

RT @JanBiegus: "Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction" Take a l…

02 Apr 2024

Reply Repost Favourite

"Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction" Take a look at latest paper in ESC HF. A post hoc exploratory analysis of the IRONMAN trial https://t.co/Ri2xHrjfWe

02 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.